Cardiovascular disease risk in subjects with type 2 diabetes mellitus in a population in southern Spain

Diabetes Research and Clinical Practice

Volumn 76, Issue 3, 2007, Pages 436-444

  Lahoz Rallo, Blanca ^a   Blanco Gonzalez, Manuel ^a   Casas Ciria, Inmaculada ^a   Marín Andrade, Jose Alberto ^a   Mendez Segovia, Juan Carlos ^a   Moratalla Rodriguez, Guillermo ^a   Quintero Dominguez, Rafael ^a   Ramirez Raya, Manuel ^a   Guerrero Pinedo, Maria Jose ^a   Aguilar Diosdado, Manuel ^b  

^a Primary Care Area of Cádiz La Janda and Jerez ^*  (Spain)

^b HOSPITAL UNIVERSITARIO PUERTA DEL MAR   (Spain)

Author keywords

Cardiovascular disease; Risk factor; SCORE; Type 2 diabetes mellitus; UKPDS

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; METFORMIN; ORAL ANTIDIABETIC AGENT;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; HUMAN; HYPERTENSION; ISCHEMIC HEART DISEASE; KIDNEY DISEASE; MAJOR CLINICAL STUDY; MALE; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PREDICTION; RETINOPATHY; SPAIN; STROKE; SYSTOLIC BLOOD PRESSURE;

ADULT; AGED; AGED, 80 AND OVER; CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; PREVALENCE; RISK; SMOKING; SPAIN;

EID: 33947596832     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2006.09.028     Document Type: Article

References (50)

1. Kannel W.B., McGee D., and Gordon T. A general cardiovascular risk profile: the Framingham Study. Am. J. Cardiol. 38 (1976) 46-51
2. Fuller J.H., Shipley M.J., Rose G., Jarrett R.J., and Keen H. Mortality from coronary heart disease and stroke in relation to degree of glycaemia: the Whitehall study. Br. Med. J. 287 (1983) 867-870
3. Barrado Lanzarote M.J., Medrano Albero M.J., and Almazan Isla J. Mortalidad por cardiopatía isquémica en España: tendencias y distribuciones geográficas. Rev. Esp. Cardiol. 48 (1995) 106-114
4. Barrado-Lanzarote M.J., Almazan-Isla J., Medrano-Albero M.J., and de Pedro-Cuesta J. Spatial distribution of stroke mortality in Spain 1975-1986. Neuroepidemiology 14 4 (1995) 165-173
5. Villar Alvarez F., Banegas Banegas J.R., Rodriguez Artalejo F., and del Rey Calero J. Mortalidad cardiovascular en España y sus comunidades autónomas. Med. Clin. (Barc.) 110 9 (1998) 321-327
6. Goday A., and Serrano-Rios M. Epidemiología de la diabetes mellitus en España. Revisión crítica y nuevas perspectivas. Med. Clin. (Barc.) 102 8 (1994) 306-315
7. Masia R., Pena A., Marrugat J., Sala J., Vila J., Pavesi M., Covas M., Aubo C., and Elosua R. High prevalence of cardiovascular risk factors in Gerona, Spain, a province with low myocardial infarction incidence. REGICOR Investigators. J. Epidemiol. Community Health 52 11 (1998) 707-715
8. Conroy R.M., et al. Estimation of 10-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur. Heart J. 24 11 (2003) 987-1003
9. Stevens R.J., Kothari V., Adler A.I., Stratton I.M., and United Kingdom Prospective Diabetes Study (UKPDS) Group. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). Clin. Sci. (Lond.) 101 6 (2001) 671-679 (Erratum in: Clin. Sci. (Lond.) 102(6) (2002) 679)
10. Kothari V., Stevens R.J., Adler A.I., Stratton I.M., Manley S.E., Neil H.A., et al. UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective. Diabetes Study risk engine. Stroke 33 7 (2002) 1776-1781
11. Menotti A., Puddu P.E., and Lanti M. Comparison of the Framingham risk function-based coronary chart with risk function from an Italian population study. Eur. Heart J. 21 5 (2000) 365-370
12. Hense H.W., Schulte H., Lowel H., Assmann G., and Keil U. Framingham risk function overestimates risk of coronary heart disease in men and women from Germany-results from the MONICA Augsburg and the PROCAM cohorts. Eur. Heart J. 24 10 (2003) 937-945
13. Costa B., Cabre J.J., Martin F., Pinol J.L., Basora J., and Blade J. Grupo de investigación ITG, La escala de Framingham sobrevalora el riego cerebral de la diabetes y el síndrome metabólico en la población española. Aten Primaria 35 8 (2000) 392-398
14. Stevens R.J., Coleman R.L., Adler A.I., Stratton I.M., Matthews D.R., and Holman R.R. Risk factors for myocardial infarction case fatality and stroke case fatality in type 2 diabetes: UKPDS 66. Diabetes Care 27 1 (2004) 201-207
15. American Diabetes Association, Standard of medical care in diabetes. Standard of medical care in diabetes. Diabetes Care 28 (2004) 34-36
16. Olveira-Fuster G., Olvera-Marquez P., Carral-Sanlaureano F., Gonzalez-Romero E., Aguilar-Diosdado M., and Soriguer F. Excess Hospitalizations, Hospital Days, and Inpatient Costs Among People With Diabetes in Andalusia, Spain. Diabetes Care 27 (2004) 1904-1909
17. De Backer G., Ambrosioni E., Borch-Johnsen K., Brotons C., Cifkova R., Dallongeville J., et al. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur. Heart J. 24 17 (2003) 1601-1610
18. Rodriguez Artalejo F., Banegas Banegas J.R., and Oya Otero M. Dieta y enfermedad cardiovascular. Med. Clin. (Barc.) 119 5 (2002) 180-188
19. Datos del Centro Nacional de Epidemiología del Instituto de Salud Carlos III, Madrid (citada el 15 de julio de 2005). Available at: http://193.146.50.130/morta/grafs.php-grafs.
20. Marrugat J., Elosua R., and Marti H. Epidemiología de la cardiopatía isquémica en España: estimación del número de casos y de las tendencias entre 1997-2005. Rev. Esp. Cardiol. 55 4 (2002) 337-346
21. Navarro Lopez V., and Benach de Rovira J. Desigualdades de salud en España. Informe de la Comisión Científica de estudios de desigualdades sociales de salud en España. Rev. Esp. Salud. Publica. 70 5/6 (1996) 503-506
22. Brotons C., Royo-Bordonada M.A., Alvarez-Sala L., Armario P., Artigao R., Conthe P., et al. Comite Espanol Interdisciplinario para la Prevencion Cardiovascular (CEIPC). Adapatción española de la Guía Europea de Prevención Cardiovascular. Aten Primaria 34 8 (2005) 427-432
23. Ministerio de Sanidad y Consumo, Madrid, 2000. Evidencia de la eficacia de la promoción de salud (citada el 15 de julio de 2005). Available at: http://www.msc.es/salud/epidemiologia/home.htm.
24. Arteagoitia J.M., Larranaga M.I., Rodriguez J.L., Fernandez I., and Pinies J.A. Incidence, prevalence and coronary heart disease risk level in known type 2 diabetes: a sentinel practice network study in the Basque Country, Spain. Diabetologia 46 7 (2003) 899-909
25. Soringuer R., Rojo-Mnez J., Esteva de Antonio I., Ruiz de Adana M.S., Merelo M.J., Beltran M., et al. Prevalence of obesity in south-east Spain and its relation with social and health factors. Eur. J. Epidemiol. 19 (2004) 32-40
26. Gimeno Orna J.A., Lou Arnal L.M., Molinero Herguedas E., Boned Julian B., and Portilla Cordoba D.P. Influencia del síndrome metabólico en el riesgo cardiovascular de pacientes con diabetes tipo 2. Rev. Esp. Cardiol. 57 6 (2004) 507-513
27. Alvarez-Sala L.A., Suarez C., Mantilla T., Franch J., Ruilope L.M., Banegas J.R., et al. Grupo PREVENCAT. Estudio PREVENCAT: control de riesgo cardiovascular en atención primaria. Med. Clin. (Barc.) 124 11 (2005) 406-410
28. Rius Riu F., Salinas Vert I., Lucas Martin A., Romero Gonzalez R., and Sanmarti Sala A. A prospective study of cardiovascular disease in patients with Type 2 diabetes. 6.3 years of follow-up. J Diabetes Complicat. 17 5 (2003) 235-242
29. Jimeno Mollet J., Molist Brunet N., Franch Nadal J., Serrano Borraz V., Serrano Barragan L., and Gracia Gimenez R. Variabilidad en la estimación del riesgo coronario en la diabetes mellitus tipo 2. Aten Primaria 35 1 (2005) 30-36
30. Junta de Andalucía, Consejería de Salud. Estudio Dreca: dieta y riesgo de enfermedades cardiovasculares en Andalucía, Consejería de Salud, Sevilla, 1999.
31. Kannel W.B., and McGee D.L. Diabetes and cardiovascular disease. The Framingham study. JAMA 241 19 (1979) 2035-2038
32. Winocour P.H., and Fisher M. Prediction of cardiovascular risk in people with diabetes. Diabet. Med. 20 7 (2003) 515-527
33. Gu K., Cowie C.C., and Harris M.I. Diabetes and decline in heart disease mortality in US adults. JAMA 281 14 (1999) 1291-1297
34. UK Prospective Diabetes Study 6, Complications in newly diagnosed type 2 diabetic patients and their association with different clinical and biochemical risk factors. Diabetes Res. 13 1 (1990) 1-11
35. Turner R.C., Millns H., Neil H.A., Stratton I.M., Manley S.E., Matthews D.R., et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br. Med. J. 316 (1998) 823-828
36. Haffner S.M., Lehto S., Ronnemaa T., Pyorala K., and Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in non-diabetic subjects with and without prior myocardial infarction. N. Engl. J. Med. 339 4 (1998) 229-234
37. Evans J.M., Wang J., and Morris A.D. Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studies. Br. Med. J. 324 (2002) 939-942 (Erratum in: Br. Med. J. 324 (2002) 1357)
38. Hu F.B., Stampfer M.J., Solomon C.G., Liu S., Willett W.C., Speizer F.E., et al. The impact of diabetes mellitus on mortality from all causes and coronary heart disease in women: 20 years of follow-up. Arch. Intern. Med. 161 14 (2001) 1717-1723
39. Becker A., Bos G., de Vegt F., Kostense P.J., Dekker J.M., Nijpels G., et al. Cardiovascular events in type 2 diabetes: comparison with non-diabetic individuals without and with prior cardiovascular disease. Ten-year follow-up of the Hoorn Study. Eur. Heart J. 24 15 (2003) 1406-1413
40. Eberly L.E., Cohen J.D., Prineas R., Yang L., and Intervention Trial Research Group. Impact of incident diabetes and incident nonfatal cardiovascular disease on 18-year mortality: the multiple risk factor intervention trial experience. Diabetes Care 26 3 (2003) 848-854
41. Lee C.D., Folsom A.R., Pankow J.S., Brancati F.L., and Atherosclerosis Risk in Communities (ARIC) Study Investigators. Cardiovascular events in diabetic and non-diabetic adults with or without history of myocardial infarction. Circulation 109 7 (2004) 855-860 (Epub February 2, 2004)
42. Vaccaro O., Eberly L.E., Neaton J.D., Yang L., Riccardi G., Stamler J., and Multiple Risk Factor Intervention Trial Research Group. Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screens of the Multiple Risk Factor Intervention Trial. Arch. Intern. Med. 164 13 (2004) 1438-1443
43. Millaruelo-Trillo J. Debe equipararse el abordaje preventivo del riesgo cardiovascular en la diabetes mellitus tipo 2 a la prevención secundaria? I. FMC. Formación Médica Continuada en Atención Primaria 12 3 (2005) 155-161
44. Millaruelo-Trillo J. Debe equipararse el abordaje preventivo del riesgo cardiovascular en la diabetes mellitus tipo 2 a la prevención secundaria? II. FMC. Formación Médica Continuada en Atención Primaria 12 4 (2005) 236-245
45. Anderson K.M., Wilson P.W., Odell P.M., and Kannel W.B. An updated coronary risk profile. A statement for health professionals. Circulation 83 1 (1991) 356-362
46. Wilson P.W., D'Agostino R.B., Levy D., Belanger A.M., Silbershatz H., and Kannel W.B. Prediction of coronary heart disease using risk factor categories. Circulation 97 18 (1998) 1837-1847
47. Yusuf S., Reddy S., Ounpuu S., and Anand S. Global burden of cardiovascular diseases. Part II. variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. Circulation 104 23 (2001) 2855-2864
48. Ramos R., Solanas P., Cordon F., Rohlfs I., Elosua R., Sala J., et al. Comparación de la función Framingham original y la calibrada del REGICOR en la predicción del riesgo coronario poblacional. Med. Clin. (Barc.) 121 14 (2003) 521-526
49. Marrugat J., Fiol M., Sala J., Jormo M.J., Segura A., Muniz J., et al. Variabilidad geográfica en España en las tasas de incidencia y mortalidad poblacionales por infarto agudo de miocardio en el estudio IBERICA. Rev. Esp. Cardiol. 53 Suppl. 2 (2000) 71-76
50. Marrugat J., Solanas P., and D'Agostino R. Estimación del riesgo coronario en España mediante la ecuación de Framingham calibrada. Rev. Esp. Cardiol. 56 3 (2003) 253-261